Navigation Links
Novo Nordisk Creates First Mobile Application to Help Doctors Diagnose Bleeding Disorders
Date:2/4/2011

PRINCETON, N.J., Feb. 4, 2011 /PRNewswire/ -- Novo Nordisk announced today the availability of Coags Uncomplicated – the first mobile application (app) to assist in the diagnosis of bleeding disorders – created in partnership with Craig Kessler, MD, Professor of Medicine and Pathology and Director of the Coagulation Laboratory, Georgetown University Hospital, Lombardi Comprehensive Cancer Center. Coags Uncomplicated features a Lab Value Analyzer that enables physicians to input test results and receive a list of potential diagnoses to consider including a description of each bleeding disorder and typical lab values.  The app also provides step-by-step suggestions for appropriate lab tests to narrow possible diagnoses.

With the potential to help clinicians quickly and more accurately diagnose bleeding disorders, the app provides for the first time, in one place, information about bleeding disorders and their effects on coagulation laboratory tests.

"While physicians are increasingly using hand-held devices to access medical information, no such tool has existed to help with the diagnosis of bleeding disorders, especially when getting to the correct diagnosis quickly may be critical," said Eddie Williams, Vice President, Biopharmaceuticals.  "Novo Nordisk was pleased to collaborate with Dr. Kessler on this innovative approach to addressing an unmet need, further demonstrating our commitment to the bleeding disorder community."

The basis for the app came from U.S. market research results, which identified a gap in many specialists' recognition of abnormal blood clotting activity in a bleeding patient; often resulting in a focus on the location of the bleed rather than the cause.  These findings were presented at the 2010 American Society of Hematology (ASH) Annual Meeting.

The Coags Uncomplicated app is available for free download at www.coagsuncomplicated.com.
'/>"/>

SOURCE Novo Nordisk
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
3. Novo Nordisk Wins Design Award for NovoTwist(TM) Needle
4. Novo Nordisk is Changing Possibilities in Hemophilia
5. Novo Nordisks Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
6. Novo Nordisk Awarded Department of Veterans Affairs National Insulin Contract
7. Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
8. Novo Nordisk Awards More Than $300,000 in Grants to Support Education and Community Health Programs
9. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
10. Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease
11. Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem® 10 mcg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , June 1, 2015 CEFALY ... electrical nerve stimulation device specifically authorized for use prior ... data from a new PET trial showing that the ... in the brain in migraine patients, namely the orbitofrontal ... Tomography (PET) scan, which is an imaging test of the brain, used ...
(Date:6/1/2015)... SETAUKET, N.Y. , June 1, 2015 /PRNewswire/ ... (NASDAQ: HRTX ) today announced positive, top-line ... study.  MAGIC evaluated the efficacy and safety of ... candidate SUSTOL ® (granisetron injection, extended release) ... intravenous (IV) neurokinin-1 (NK 1 ) receptor antagonist ...
(Date:6/1/2015)... 2015   OTC Markets Group Inc. ... financial marketplaces for 10,000 U.S. and global securities, ... Diego -based biopharmaceutical company, on its NASDAQ ... public venture market for entrepreneurial and development stage ... "We,re happy to congratulate OncoSec ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... , , INDIANAPOLIS, Dec. 18 ... today announced that Derica Rice, senior vice president and chief ... been promoted to executive vice president, global services and chief ... Rice will retain his responsibilities as chief financial officer of ...
... , , , MELBOURNE, Australia, Dec. ... New Objective , Key points: , *Single injection of ... levels and sustained reduction in blood glucose levels , ... of pancreatic islets, and increase in insulin-producing beta cells ...
Cached Medicine Technology:Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President 2Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 2Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 3
(Date:6/1/2015)... June 01, 2015 Note: Dr. Julian ... in breast cancer prevention. , A phase III trial ... postmenopausal women with ductal carcinoma in situ (DCIS) now ... prevention. , The study (NSABP B-35/NRG Oncology) looked at ... the standard five-year treatment with tamoxifen to those who ...
(Date:6/1/2015)... Northridge, CA (PRWEB) June 01, 2015 ... Ramin Assili are now offering patients a promotion on ... the price of Invisalign treatment is reduced to $3,700. ... treatment during the complimentary consultation and discuss the extent ... 2015, and it cannot be combined with any other ...
(Date:6/1/2015)... MD (PRWEB) June 01, 2015 InstantLabs ... identification test as part of a Cooperative Research and ... Administration (FDA). In accordance with U.S. Farm Bill ... legally marketed as catfish within the United States. ... in hours at the point-of need rather than requiring ...
(Date:6/1/2015)... PA (PRWEB) June 01, 2015 If ... discomfort based on past experience, we have some encouraging ... from San Diego and one from San Marcos, Calif., ... a prototype for DuoOptimum Suction (DOS) Tip to provide ... other procedures. As such, it keeps a dental patient’s ...
(Date:6/1/2015)... Community Scene ( communityscene.com ), the ... of its free online platform designed to connect people ... and globally. , On Community Scene, members can share ... their community – including local news, activities for the ... can choose a home community or follow any community ...
Breaking Medicine News(10 mins):Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 2Health News:Today at ASCO: Anastrazole Offers Higher Breast Cancer-Free Survival Rates than Tamoxifen Following DCIS, Phase III Study Shows 3Health News:Northridge Dentists, Drs. Michel Elyson and Ramin Assili, are Now Offering a Limited Time Promotion on Invisalign 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 2Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 3Health News:InstantLabs Partners with FDA to Commercialize Catfish Species Identification Test 4Health News:All-in-One Dental Aspirator Invented by InventHelp® Clients (SDB-733) 2Health News:Community Scene Launches the Largest Global Social Network for Communities 2
... usually go undetected during the early stages, according to ... initial symptoms of the condition, according to the // ... symptoms are the clubbed finger, swollen fingertips, and chest ... of the lungs or an analysis of the mucus ...
... and celecoxib (Celebrex) reduces breast cancer risk by 71%, ... of Medicine and Public Health's Randall Harris led the ... nonsteroidal anti-inflammatory drugs (NSAIDs) play a prominent role in ... researchers observed that while daily use of selective COX-2 ...
... turned out to be negative for the presence of ... by the health minister Datuk Dr Chua Soi Lek. ... however. ,The victim, Norhayati Awang is currently ... Raja Perempuan Zainab II. According to official reports, she ...
... had developed a new technology that will help in the ... a high risk. It is a blood test, which measures ... can detect typical; changes seen in the early liver cancer ... because live cancer is one of the most prevalent diseases. ...
... flu virus here comes another virus that us causing havoc. Known ... that manifests itself in the form of severe vomiting and diarrhea. ... the Norwalk virus. ,The virus has been known to affect ... as of now. What is concerning the authorities ...
... e-mail contribute towards strengthening and expanding social ties among the ... American Life Project. //It had earlier been said that social ... ,With the help of the Internet, people are ... though many of the people in those networks do not ...
Cached Medicine News:Health News:Early Detection Of Primary Liver Cancer Would Save Millions Of Lives 2
... The Magnes 2500 WH , with its ... full cortical coverage allowing the localization of ... millisecond temporal resolution and millimeter spatial resolution. ... secure patient database and rapid data processing ...
... and table configurations designed for a wide ... can capture 17 X 17 X-ray images ... flexible system includes a Bucky table, upright ... ceiling suspended multi-positioning unit. Versatile and economical, ...
The Oscor PACE 203 H is the third generation of Osypka line of External Dual Chamber Pacemakers. Based on over 20 years of pacing experience, the PACE 203 H represents todays standard in temporary du...
... Oscors proprietary quadripolar pacing ... consistent pacing and sensing in ... combining two bipolar wires in ... for the atrium and ventricle ...
Medicine Products: